Literature DB >> 26540338

Trisubstituted Thieno[3,2-b]pyrrole 5-Carboxamides as Potent Inhibitors of Alphaviruses.

Kuan-Chieh Ching1,2, Yiu-Wing Kam3, Andres Merits4, Lisa F P Ng3,5, Christina L L Chai1,2,6.   

Abstract

Chikungunya virus (CHIKV) is a re-emerging vector-borne alphavirus and is transmitted to humans by Aedes mosquitoes. Despite the re-emergence of CHIKV as an epidemic threat, there is no approved effective antiviral treatment currently available for CHIKV. Herein, we report the synthesis and structure-activity relationship studies of a class of thieno[3,2-b]pyrroles and the discovery of a trisubstituted thieno[3,2-b]pyrrole 5-carboxamide 15c that exhibits potent inhibitory activity against in vitro CHIKV infection. Compound 15c displayed low micromolar activity (EC50 value of ca. 2 μM) and limited cytotoxic liability (CC50 > 100 μM) therefore furnishing a selectivity index of greater than 32. Notably, 15c not only controlled viral RNA production, but efficiently inhibited the expression of CHIKV nsP1, nsP3, capsid, and E2 proteins at a concentration as low as 2.5 μM. More importantly, 15c also demonstrated broad spectrum antiviral activity against other clinically important alphaviruses such as O'nyong-nyong virus and Sindbis virus.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26540338     DOI: 10.1021/acs.jmedchem.5b01047

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  7 in total

1.  Design and Validation of Novel Chikungunya Virus Protease Inhibitors.

Authors:  Pratyush Kumar Das; Laura Puusepp; Finny S Varghese; Age Utt; Tero Ahola; Dzmitry G Kananovich; Margus Lopp; Andres Merits; Mati Karelson
Journal:  Antimicrob Agents Chemother       Date:  2016-11-21       Impact factor: 5.191

2.  The Antiviral Alkaloid Berberine Reduces Chikungunya Virus-Induced Mitogen-Activated Protein Kinase Signaling.

Authors:  Finny S Varghese; Bastian Thaa; Siti Naqiah Amrun; Diane Simarmata; Kai Rausalu; Tuula A Nyman; Andres Merits; Gerald M McInerney; Lisa F P Ng; Tero Ahola
Journal:  J Virol       Date:  2016-10-14       Impact factor: 5.103

3.  VCP/p97 Is a Proviral Host Factor for Replication of Chikungunya Virus and Other Alphaviruses.

Authors:  Guillaume Carissimo; Yi-Hao Chan; Age Utt; Tze-Kwang Chua; Farhana Abu Bakar; Andres Merits; Lisa F P Ng
Journal:  Front Microbiol       Date:  2019-09-24       Impact factor: 5.640

Review 4.  The medicinal chemistry of Chikungunya virus.

Authors:  Edeildo F da Silva-Júnior; Giovanni O Leoncini; Érica E S Rodrigues; Thiago M Aquino; João X Araújo-Júnior
Journal:  Bioorg Med Chem       Date:  2017-06-29       Impact factor: 3.641

5.  Inhibition by Marine Algae of Chikungunya Virus Isolated From Patients in a Recent Disease Outbreak in Rio de Janeiro.

Authors:  Claudio Cesar Cirne-Santos; Caroline de Souza Barros; Caio Cesar Richter Nogueira; Renata Campos Azevedo; Kristie Aimi Yamamoto; Guilherme Louzada Silva Meira; Zilton Farias Meira de Vasconcelos; Norman Arthur Ratcliffe; Valéria Laneuville Teixeira; Jonas Schmidt-Chanasit; Davis Fernandes Ferreira; Izabel Christina Nunes de Palmer Paixão
Journal:  Front Microbiol       Date:  2019-10-24       Impact factor: 5.640

6.  The Synthesis and Anti-Cytomegalovirus Activity of Piperidine-4-Carboxamides.

Authors:  Xin Guo; Ayan Kumar Ghosh; Robert F Keyes; Francis Peterson; Michael Forman; David J Meyers; Ravit Arav-Boger
Journal:  Viruses       Date:  2022-01-25       Impact factor: 5.048

Review 7.  Antivirals against the Chikungunya Virus.

Authors:  Verena Battisti; Ernst Urban; Thierry Langer
Journal:  Viruses       Date:  2021-07-05       Impact factor: 5.048

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.